BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28760294)

  • 1. Management of Patients With Histologic Transformation.
    Reddy NM
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S100-S104. PubMed ID: 28760294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of follicular lymphoma.
    Lossos IS; Gascoyne RD
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):147-63. PubMed ID: 21658615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformed follicular non-Hodgkin lymphoma.
    Casulo C; Burack WR; Friedberg JW
    Blood; 2015 Jan; 125(1):40-7. PubMed ID: 25499449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third biannual report of the Cochrane Haematological Malignancies Group.
    Kober T; Skoetz N; Trelle S; Bohlius J; Engert A;
    J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
    Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.
    Wirk B; Fenske TS; Hamadani M; Zhang MJ; Hu ZH; Akpek G; Aljurf MD; Armand P; Ayala E; Bachanova V; Bolwell B; Cairo MS; Cashen A; Chen YB; Costa LJ; Farhan S; Freytes CO; Gajewski JL; Gibson J; Hale GA; Holmberg LA; Hsu JW; Inwards DJ; Kamble RT; Maharaj D; Maziarz RT; Munker R; Nath R; Reddy NM; Reeder CB; Rizzieri DA; Sauter CS; Savani BN; Schouten HC; Sureda A; Vose JM; Waller EK; Wiernik PH; Gale RP; Burns LJ; Saber W
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):951-9. PubMed ID: 24641828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.
    Bento L; Boumendil A; Finel H; Le Gouill S; Amorim S; Monjanel H; Bouabdallah R; Bay JO; Nicolas-Virelizier E; McQuaker G; Rossi G; Johnson R; Huynh A; Ceballos P; Rambaldi A; Bachy E; Malladi R; Orchard K; Pohlreich D; Tilly H; Bonifazi F; Poiré X; Guilhot F; Haenel A; Crawley C; Metzner B; Gribben J; Russell NH; Damaj G; Thomson K; Dreger P; Montoto S
    Bone Marrow Transplant; 2017 Aug; 52(8):1120-1125. PubMed ID: 28530668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.
    Nademanee A; Forman SJ
    Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma.
    Vose JM; Bierman PJ; Lynch JC; Weisenburger DD; Kessinger A; Chan WC; Greiner TC; Armitage JO
    J Clin Oncol; 1998 Mar; 16(3):844-9. PubMed ID: 9508164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation strategies for patients with follicular lymphoma.
    Buske C; Dreyling M; Unterhalt M; Hiddemann W
    Curr Opin Hematol; 2005 Jul; 12(4):266-72. PubMed ID: 15928482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.
    Krishnan A; Nademanee A; Fung HC; Raubitschek AA; Molina A; Yamauchi D; Rodriguez R; Spielberger RT; Falk P; Palmer JM; Forman SJ
    J Clin Oncol; 2008 Jan; 26(1):90-5. PubMed ID: 18025438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic cell transplantation for lymphomas.
    Ayala E; Tomblyn M
    Cancer Control; 2011 Oct; 18(4):246-57. PubMed ID: 21976243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma.
    Villanueva ML; Vose JM
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):521-30. PubMed ID: 17147239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.
    Wong E; Dickinson M
    Curr Oncol Rep; 2012 Oct; 14(5):424-32. PubMed ID: 22865028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma].
    Ogura M
    Rinsho Ketsueki; 2008 Oct; 49(10):1434-50. PubMed ID: 18833928
    [No Abstract]   [Full Text] [Related]  

  • 16. Histologic transformation of follicular lymphoma after allogeneic bone marrow transplantation.
    Kojima K; Mannami T; Yoshino T; Kawasaki H; Sasaki K; Maeda T; Furuya K; Harada M; Hara M
    Bone Marrow Transplant; 2000 Sep; 26(5):581-3. PubMed ID: 11019852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of diffuse large B-cell lymphoma from duodenal type follicular lymphoma: a retrospective study of 23 cases.
    Saburi M; Kondo Y; Ogata M; Soga Y; Abe M; Takano K; Kohno K; Nagai T; Nakayama T
    Int J Hematol; 2020 Nov; 112(5):658-665. PubMed ID: 32740764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is allogeneic stem cell transplantation for transformed follicular lymphoma anti-lymphoma stem cell therapy?
    Ritchie DS
    Leuk Lymphoma; 2008 Oct; 49(10):1852-3. PubMed ID: 18949608
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose chemotherapy followed by autologous and allogeneic hematopoietic stem cell transplantation in patients with follicular non-Hodgkin’s lymphoma in the rituximab era.
    Escobar IG; Sánchez de Ibarguen BC; de Juan VC; Alonso CM; García MM; Ruíz AC; Pulla MP
    Tumori; 2015; 101(1):2-7. PubMed ID: 25702654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
    Derenzini E; Musuraca G; Fanti S; Stefoni V; Tani M; Alinari L; Venturini F; Gandolfi L; Baccarani M; Zinzani PL
    Cancer; 2008 Nov; 113(9):2496-503. PubMed ID: 18833583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.